drugset / Trial / NCT06297434
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study aims to evaluate the safety of J2H-1702 compared to the placebo and explore the efficacy of J2H-1702 at Week 12 timepoint after administration compared to baseline in patients with NASH.
Timeline
- Start
- 2023-02-15
- Primary completion
- 2025-06-26
- Completion
- 2025-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | J2H-1702 | Unknown | — | Oral |